(MENAFN- Baystreet) PGT Unchanged on New Website
Amgen Enters Weight-Loss Market
Intel, AMD Dip on China Moves
European Union Targets Big Tech In Antitrust Probe
Today's Hottest Trades: Nike, Lululemon, and FedEx Previous Articles Subscribe to Get Small Cap News & Alerts Glenn Wilkins - Monday, March 25, 2024
Nvidia States Case
Last week, Nvidia (NASDAQ:NVDA) announced deals with Johnson & Johnson (NYSE:JNJ) for use of generative AI in surgery, and with GE Healthcare (NYSE:GE) to improve medical imaging. The health care developments at its 2024 GTC AI conference, - which also included the launch of roughly two dozen new AI-powered, healthcare-focused tools - demonstrate just how important medicine is to Nvidia's non-tech sector revenue opportunities in the future.
“The reason why Nvidia is so popular today is because it basically provided the plumbing and the technology for something that you could not do simply before or if you had to do something like this you would need probably several times more time, money and cost,” said Raj Joshi, a technology analyst and senior vice president at Moody's Ratings.“Health care, whether it's biotechnology, chemicals, or drug discovery is a very powerful area.”
Nvidia shares are up close to 100% year-to-date, and the biotech industry is an example of the untapped potential that investors are continue to bet on. AI can speed up the process of drug discovery and even find uses for drugs that may have failed to produce results for the initial disease they were developed to target.
“Over the last 18 months or so, we tend to believe it is more hope than hype because of the tangible outcomes and then the very compelling use cases how AI helped with the pharmaceutical industry, medtech industry or biotech industry,” said Arda Ural, EY Americas health and life sciences industry market leader.
NVDA shares began Monday up $22.32, or 2.4%, to $965.36.
About Us Contact Us Advertise License Our Content Jobs Disclaimer Privacy Policy
Copyright 1998 - 2024 Baystreet Media Corp. All rights reserved. Nasdaq Stocks: Information delayed 15 minutes. Non-Nasdaq Stocks: Information delayed 20 minutes. Bid and Ask quotation information for NYSE and AMEX securities is only available on a real time basis. Market Data is provided by QuoteMedia. Earnings by Zacks. Analyst Ratings by Zacks
MENAFN25032024000212011056ID1108019776
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.